Home Stem Cells & Wnt Stemness kinase

Stemness kinase

Choose Selective Stemness kinase Inhibitors

Stemness kinase Products

  • All (1)
  • Stemness kinase Inhibitor (1)
  • New Stemness kinase Products
Catalog No. Product Name Information Product Use Citations Product Validations
S8572 Amcasertib (BBI503) Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.
Cell Rep, 2022, 38(7):110390
Sci Rep, 2022, 12(1):7
Cell Death Dis, 2020, 11(8):670
S8572 Amcasertib (BBI503) Amcasertib (BBI503), a first-in-class cancer stemness kinase inhibitor, is claimed to inhibit Nanog and other CSC pathways by targeting kinases with potential anticancer activity.
Cell Rep, 2022, 38(7):110390
Sci Rep, 2022, 12(1):7
Cell Death Dis, 2020, 11(8):670
Tags: Stemness kinase Inhibition | Stemness kinase Activation | Stemness kinase Inhibitor | Stemness kinase activator | Stemness kinase Activity | Stemness kinase phosphorylation| CSC pathway